NCT03794245

Brief Summary

This clinical trial seeks to determine if male-centered recruitment increases men's testing for HIV and whether or not individualized introduction to clinics increases male engagement in treatment for HIV. The study is being conducted in rural KwaZulu Natal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,806

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 7, 2015

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

October 9, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 4, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
Last Updated

July 7, 2023

Status Verified

July 1, 2023

Enrollment Period

6.4 years

First QC Date

October 9, 2018

Last Update Submit

July 6, 2023

Conditions

Keywords

PreventionTesting and DiagnosisTreatment

Outcome Measures

Primary Outcomes (1)

  • Percentage of men tested for HIV

    Percentage of men in the community, selected through probability sampling, who report being tested for HIV

    Tested within the past 12 months

Other Outcomes (2)

  • Percentage of HIV+ men initiating treatment for HIV

    Within 6 months of receiving HIV diagnosis

  • Percentage of men with suppressed viral load

    12 months after initiating treatment

Study Arms (4)

Men-Centered HIV Testing

EXPERIMENTAL

Mobile HIV testing is conducted at sites in the community where men gather.

Behavioral: Men-Centered HIV Testing

Clinic-based HIV Testing

ACTIVE COMPARATOR

Men are referred to the nearest clinic for HIV counseling and testing

Behavioral: Clinic-based HIV Testing

Linkage to Care for HIV+ Men

EXPERIMENTAL

The patient coordinator arranges an appointment time at the clinic and accompanies the patient to the initial visit

Behavioral: Linkage to Care for HIV+ Men

Clinic Referral for HIV+ Men

ACTIVE COMPARATOR

Men diagnosed with HIV are referred to the nearest clinic for treatment of HIV

Behavioral: Clinic Referral for HIV+ Men

Interventions

The intervention involves bringing mobile HIV testing to venues where men congregate, talking to them as a group about HIV testing, and then providing testing at that venue.

Men-Centered HIV Testing

Men diagnosed with HIV are accompanied to the clinic and registered there with the help of a community health worker.

Linkage to Care for HIV+ Men

Individuals present to a clinic and request HIV counseling and testing

Clinic-based HIV Testing

Individuals diagnosed with HIV are referred to the nearest clinic for treatment of HIV

Clinic Referral for HIV+ Men

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men residing in the target communities

You may not qualify if:

  • Men outside of the target communities
  • Men who report being tested and HIV+

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Human Sciences Research Council

Pietermaritzburg, KwaZulu-Natal, South Africa

Location

Related Publications (1)

  • van Rooyen H, Makusha T, Joseph P, Ngubane T, Kulich M, Sweat M, Coates T. Zwakala Ndoda: a cluster and individually randomized trial aimed at improving testing, linkage, and adherence to treatment for hard-to reach men in KwaZulu-Natal, South Africa. Trials. 2019 Dec 30;20(1):798. doi: 10.1186/s13063-019-3908-0.

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeDisease

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • THOMAS J COATES, PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR
  • Heidi Van Rooyen, PhD

    Human Sciences Research Council

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
The Care Provider and Outcomes Assessors do not know the arms to which an individual has been assigned
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Men-Centered HIV Testing vs. Clinic-Based HIV Testing; Personalized Linkage to Care for HIV+ Men vs. Clinic Referral for HIV+ Men.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 9, 2018

First Posted

January 4, 2019

Study Start

July 7, 2015

Primary Completion

December 1, 2021

Study Completion

April 30, 2022

Last Updated

July 7, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations